Dublin, July 15, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/r3dsk2/biopharmaceuticals) has announced the addition of the "Biopharmaceuticals - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Biopharmaceuticals in US$ Million by the following Segments: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 514 companies including many key and niche players such as:
- AbbVie, Inc. (US)
- Anavex Life Sciences Corp. (US)
- Baxter International, Inc. (US)
- Bayer HealthCare Pharmaceuticals, Inc. (US)
- Biocon (India)
- Eli Lilly (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Genentech (US)
- GlaxoSmithKline (UK)
- Janssen Biotech, Inc. (US)
- Kemwell Biopharma (India)
- Novartis (Switzerland)
- Sandoz
- Pfizer, Inc. (US)
- Sun Pharmaceutical Industries Ltd. (India)
- Sanofi S.A. (France)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. SEGMENT ANALYSIS
3. BIOPHARMACEUTICALS IN THE PIPELINE
4. MARKET TRENDS
5. BIOPHARMACEUTICALS
6. PRODUCT LAUNCHES/APPROVALS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 514 (including Divisions/Subsidiaries 525)
- The United States (300)
- Canada (14)
- Japan (5)
- Europe (137)
- - France (21)
- - Germany (21)
- - The United Kingdom (12)
- - Italy (5)
- - Spain (3)
- - Rest of Europe (75)
- Asia-Pacific (Excluding Japan) (60)
- Middle East (9)
For more information visit http://www.researchandmarkets.com/research/r3dsk2/biopharmaceuticals